The New Opto XLink has been designed with state-of-the-art technology to provide safe and effective treatment.
The New Opto XLink has been designed with state-of-the-art technology to provide safe and effective treatment.
The optical system of The New Opto-XLink has been developed to deliver a high dose of energy, in a collimated and homogeneous manner, over the cornea to be treated.
In addition The New Opto-XLink has an internal microprocessor system (microcomputer) which, through sophisticated software, controls all the equipment's functions.
Using internal sensors, The New Opto-XLinksystem constantly monitors the amount of energy emitted.
It also offers:
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
goldfarma © 2025 all rights reserved
